# What every medical affairs leader needs to know about generative AI in pharma

Join us for an insight-packed discussion on: “What every medical affairs leader needs to know about generative AI in pharma,” featuring healthcare experts [Rob Stevens](https://www.linkedin.com/in/robertstevens/) and [Zayed Yasin](https://www.linkedin.com/in/zayed-yasin/), MD.

Discover the current state of generative AI in medical affairs, explore real-world applications, and get practical advice based on decades of combined experience at firms including Novartis and Pfizer.

## What you'll learn:

|     |     |
| --- | --- |
|  | Industry perspective on the current state of generative AI in pharma, particularly in medical affairs |
|  | Practical ways to use generative AI in medical affairs today |
|  | Critical considerations such as challenges, risks, and legal/ regulatory constraints involved. |

## Who should attend:

|     |     |
| --- | --- |
|  | Leaders in medical affairs and commercial groups at pharma companies |
|  | Pharma tech and IT leaders |